Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults

Pavliv, Leo; Voss, Bryan; Rock, Amy
January 2011
American Journal of Health-System Pharmacy;1/1/2011, Vol. 68 Issue 1, p47
Academic Journal
Purpose. The pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults were evaluated. Methods. In this randomized, doubleblind, placebo-controlled, single-dose, crossover study, 12 healthy subjects age 18-65 years were randomized to receive a single dose of either 800 mg i.v. ibuprofen (infused over five to seven minutes) concomitantly with an oral placebo or 800 mg oral ibuprofen with concomitant i.v. placebo (0.9% sodium chloride injection). After a six-day washout period, subjects received the treatment not previously received. Blood samples were taken 1 hour before each dose of study medication was administered and throughout the 12 hours thereafter. Plasma ibuprofen concentrations were determined using validated liquid chromatography-tandem mass spectrometry methods. The frequency and severity of treatment-emergent adverse effects were monitored throughout the study. Results. The maximum plasma concentration (Cmax) of i.v. ibuprofen was approximately twice that of oral ibuprofen, and the (tmax) of i.v. ibuprofen was 0.11 hour, compared with 1.5 hours for oral ibuprofen. However, the elimination half-life of i.v. and oral ibuprofen did not differ, both of which were approximately 2 hours. Oral ibuprofen was 100% bioavailable; therefore, the area under the concentration-time curve did not differ between i.v. and oral ibuprofen. In addition, i.v. ibuprofen infused over five to seven minutes did not differ in terms of safety or tolerability when compared with oral ibuprofen. Conclusion. I.V. ibuprofen, when administered over five to seven minutes in healthy subjects, achieved a higher Cmax and a more-rapid tmax than did oral ibuprofen and was found to be safe and well tolerated.


Related Articles

  • Comparison of plaque removal efficacy of new and 3-month-old toothbrushes in children. Malekafzali, B.; Biria, M.; Tadayon, N.; Abbasi, H. // Eastern Mediterranean Health Journal;Feb2011, Vol. 17 Issue 2, p115 

    The cost of replacing toothbrushes at frequent intervals may be prohibitive in underdeveloped countries. The objective of this study in Tehran was to compare the plaque removal efficacy of new and 3-month-old toothbrushes in children. In a randomized, crossover study, 93 children aged 7-9 years...

  • Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia. Koren, Michael J.; Hamad, Abdullah; Klasen, Sally; Abeyratne, Anura; McNutt, Bruce E.; Kalra, Sanjay // American Journal of Health-System Pharmacy;5/1/2011, Vol. 68 Issue 9, p818 

    Purpose. The efficacy and safety of conivaptan administered via 30-minute i.v. infusion to patients with euvolemic or hypervolemic hyponatremia were evaluated. Methods. Hospitalized adults with a baseline serum sodium concentration (SSC) of 115-130 meq/L and euvolemia or hypervolemia on clinical...

  • Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers. Teng, Renli; Mitchell, Patrick; Butler, Kathleen // European Journal of Clinical Pharmacology;Mar2013, Vol. 69 Issue 3, p477 

    Purpose: Interactions between ticagrelor and atorvastatin or simvastatin were investigated in two-way crossover studies. Methods: Both studies were open-label for statin; the atorvastatin study was placebo-controlled for ticagrelor. For atorvastatin, volunteers ( n = 24) received ticagrelor...

  • Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers. Tanaka, Jun; Kasai, Hidefumi; Shimizu, Kenji; Shimasaki, Shigeki; Kumagai, Yuji // European Journal of Clinical Pharmacology;Mar2013, Vol. 69 Issue 3, p489 

    Purpose: We performed a population pharmacokinetic analysis of phenytoin after intravenous administration of fosphenytoin sodium in healthy, neurosurgical, and epileptic subjects, including pediatric patients, and determined the optimal dose and infusion rate for achieving the therapeutic range....

  • Bioavalaibility and pharmacokinetic comparison of two formulations of metformin 850 mg tablets in healthy Colombian volunteers. HOLGUÍN, GLORIA; CUESTA, FANNY; ARCHBOLD, ROSENDO; RESTREPO, MARGARITA; PARRA, SERGIO; PEÑA, LINA; MONTOYA, BLANCA; RÍOS, JUAN CARLOS; TORO, VICTORIA EUGENIA; RUIZ, ADRIANA // Colombia Medica;ene-mar2011, Vol. 42 Issue 1, p81 

    Purpose: The aim of this study was to compare the bioavailability of two formulations of metformin 850 mg tablets: Glucophage® from Merck Santè laboratories (reference product) and Metformin from Winthrop Pharmaceuticals de Colombia SA (test product) in healthy Colombian volunteers....

  • Melatonin: Can It Stop the Ringing? Hurtuk, Agnes; Dome, Claudia; Holloman, Christopher H.; Wolfe, Kelly; Welling, Bradley; Dodson, Edward E.; Jacob, Abraham // Annals of Otology, Rhinology & Laryngology;Jul2011, Vol. 120 Issue 7, p433 

    Objectives: We sought to report the efficacy of oral melatonin as treatment for chronic tinnitus and to determine whether particular subsets of tinnitus patients have greater benefit from melatonin therapy than others. Methods: This was a prospective, randomized, double-blind, crossover clinical...

  • Microbiological contamination of toothbrushes and identification of a decontamination protocol using chlorhexidine spray. Rodrigues, Lais Kuhn; Motter, Cintia Werner; Pegoraro, Daniele Aiache; Vicente Menoli, Ana Paula; Menolli, Rafael Andrade // Revista Odonto Ciencia;2012, Vol. 27 Issue 3, p213 

    Purpose: This study evaluated the rate of microbial contamination of toothbrushes used by students and established a protocol for the spraying of 0.12% chlorhexidine to decrease the bacterial presence on the bristles of the brushes. Methods: We performed cultures on selective and nonselective...

  • The influence of tocolytic drugs on cardiac function, large arteries, and resistance vessels. Fabry, Isabelle; Paepe, Peter; Kips, Jan; Bortel, Luc // European Journal of Clinical Pharmacology;Jun2011, Vol. 67 Issue 6, p573 

    Purpose: Beta-2 adrenoceptor agonistic drugs like ritodrine have been the reference tocolytic drugs, but are associated with cardiovascular side-effects. Atosiban, a newer drug, is a competitive antagonist of oxytocin and has been claimed to have fewer cardiovascular side effects. Until now,...

  • Effects of myofascial release techniques on pain, physical function, and postural stability in patients with fibromyalgia: a randomized controlled trial. Castro-Sánchez, Adelaida María; Matarán-Peñarrocha, Guillermo A; Arroyo-Morales, Manuel; Saavedra-Hernández, Manuel; Fernández-Sola, Cayetano; Moreno-Lorenzo, Carmen // Clinical Rehabilitation;Sep2011, Vol. 25 Issue 9, p800 

    Objective: To determine the effect of myofascial release techniques on pain symptoms, postural stability and physical function in fibromyalgia syndrome.Design: A randomized, placebo-controlled trial was undertaken.Subjects: Eighty-six patients with fibromyalgia syndrome were randomly assigned to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics